Close menu




December 21st, 2020 | 08:39 CET

Everfuel, Triumph Gold, Varta - This will be important!

  • Investments
Photo credits: pixabay.com

The final weeks of the unique 2020 stock market year promise further excitement. The DAX is close to its all-time high of 13,808 points. If it breaks the mark, investors are likely to party, albeit at a distance, until the end of the year. Gold also resumed in the direction of the all-time high. After the strong support at USD 1,800 held, analysts see highs again for the precious yellow metal as early as the first quarter of 2021.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: CA8968121043 , DE000A0TGJ55 , DK0061414711

Table of contents:


    Strong corrections

    Owners of gold mining stocks have suffered heavy price losses since August when the gold price correction began. Now, most stocks seem to have formed a bottom. However, if the gold price continues its positive trend, mines, especially those in the second tier, could quickly return to their old price levels. The mineral exploration Company Triumph Gold has been hit hard. The highest price was in the summer at CAD 0.48. Currently, the Canadians are quoted at CAD 0.19, which means a current stock market value of only EUR 20.0 million. But at the same time, Triumph Gold is very well positioned.

    Many pillars

    The 100% owned Freegold Mining project in Yukon has enormous potential. The site, which has an excellent infrastructure, is home to several promising mineral deposits. Thus, the "Revenue" mine has copper-gold-moblydän-silver, the mine "Nucleus" has gold and at "Tinta Hill" one finds many differentiated metals. The drilling program for the full year 2021 has already been secured. Currently, Triumph Gold shows a cash balance of CAD 6.0 million. Industry giants also see the great potential of the explorer. Newmont Mining holds a 12.8% stake and the Zijn Mining Fund 9.8%.

    Market reacts calmly

    Battery manufacturer Varta was the victim of a major insider transaction at the end of last week. VGG GmbH, to which Supervisory Board Chairman Michael Tojner has a close relationship, sold securities with an equivalent value of EUR 44.0 million at a share price of EUR 110.00. VGG is the main shareholder with most recently just under 57 percent. Measured against the market capitalization of EUR 4.39 billion, the sale then looks relatively small. In any case, the sale did not have a negative impact on the price of the M-DAX Company.

    Decision approaching

    The share also reacted without any major price jumps to the announcement of the distribution of a significant dividend. For weeks, the chart has remained directionless below the resistance line at EUR 115.00 and formed a triangle formation. Should the EUR 115.00 mark be significantly broken in the next few days, the consolidation of the last few weeks would be over, and the triangle formation would be bullishly resolved. The next price target would be first the November high at EUR 125.10 and then the all-time high of September at EUR 138.70. On the downside, a break of the formation at EUR 105.0 and a breach of the critical resistance at EUR 100.0 would be fatal. It would bring more short sellers onto the scene, ones who had already used the Varta share as an underlying in the past.

    Nel Asa likes this!

    The mother is pleased. With just under 17%, the Norwegian hydrogen specialist Nel Asa still has a stake in Everfuel A/S. Now the Danes are waiting with very positive news. As already reported at the end of November, Everfuel will take over the operation and expansion of hydrogen infrastructures and filling stations in Norway. Due to this, Nel Asa gave a majority stake in its current 100% subsidiary H2 Fuel Norway AS to Everfuel. Now H2 Fuel Norway has been awarded a contract by the Climate Office of the City of Oslo in a public tender to lease a plot of land in Kjelsrud where a hydrogen filling station will be built.

    Another order in Denmark

    Everfuel is also scoring points on its home market where a memorandum of understanding has been signed with Green Hydrogen Hub Denmark. The hub is already working with Eurowind Energy, Corre Energy and GasStorage Denmark. The goal is to build a 350 MW electrolysis plant, a 200,000 MWh hydrogen storage facility and another energy storage facility. The plant is to be built between the cities of Vilborg and Hobro. An exciting project for the still young Company. However, sales and earnings are also urgently needed if the hyped stock market valuation of over EUR 530 million is to be justified. Caution is advised for private investors. The pure free float of Everfuel is just 5%.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read